These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15936534)

  • 21. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis.
    Ujike H; Sakai A; Nakata K; Tanaka Y; Kodaka T; Okahisa Y; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():90-6. PubMed ID: 17105906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case-control study provides evidence of association for a functional polymorphism -197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect.
    Chen W; Duan S; Zhou J; Sun Y; Zheng Y; Gu N; Feng G; He L
    Biochem Biophys Res Commun; 2004 Jul; 319(3):866-70. PubMed ID: 15184063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mood disorders and XBP1].
    Kato T
    Seishin Shinkeigaku Zasshi; 2004; 106(12):1593-7. PubMed ID: 15770962
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence.
    Kobayashi H; Ide S; Hasegawa J; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Shen HW; Ikeda K; Sora I
    Ann N Y Acad Sci; 2004 Oct; 1025():325-34. PubMed ID: 15542733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence.
    Morio A; Ujike H; Nomura A; Tanaka Y; Morita Y; Otani K; Kishimoto M; Harano M; Inada T; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():411-7. PubMed ID: 17105939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROKR2 is associated with methamphetamine dependence in the Japanese population.
    Kishi T; Kitajima T; Tsunoka T; Okumura T; Okochi T; Kawashima K; Inada T; Ujike H; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1033-6. PubMed ID: 20576534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
    Aoyama N; Takahashi N; Kitaichi K; Ishihara R; Saito S; Maeno N; Ji X; Takagi K; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Iwata N; Inada T; Ozaki N
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1644-9. PubMed ID: 17010131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association between endoplasmic reticulum stress response genes and suicidal victims.
    Sakurai K; Nishiguchi N; Shirakawa O; Nushida H; Ueno Y; Maeda K; Hayashi Y
    Kobe J Med Sci; 2007; 53(4):151-5. PubMed ID: 17932454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC; Thorley-Lawson DA
    J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of human X-box binding protein 1 (XBP-1) in colorectal adenomas and adenocarcinomas.
    Fujimoto T; Yoshimatsu K; Watanabe K; Yokomizo H; Otani T; Matsumoto A; Osawa G; Onda M; Ogawa K
    Anticancer Res; 2007; 27(1A):127-31. PubMed ID: 17352224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.
    Sim MS; Hatim A; Reynolds GP; Mohamed Z
    Pharmacogenomics; 2013 Apr; 14(5):505-14. PubMed ID: 23556448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence.
    Okahisa Y; Ujike H; Kotaka T; Morita Y; Kodama M; Inada T; Yamada M; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):417-22. PubMed ID: 19566775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene polymorphisms of the mu opioid receptor in methamphetamine abusers.
    Ide S; Kobayashi H; Tanaka K; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Ikeda K; Sora I
    Ann N Y Acad Sci; 2004 Oct; 1025():316-24. PubMed ID: 15542732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
    Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
    Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia.
    Ikeda M; Ozaki N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Kishi T; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Inada T; Iwata N
    Genes Brain Behav; 2007 Feb; 6(1):107-12. PubMed ID: 17233643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association study between casein kinase 1 epsilon gene and methamphetamine dependence.
    Kotaka T; Ujike H; Morita Y; Kishimoto M; Okahisa Y; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2008 Oct; 1139():43-8. PubMed ID: 18991847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode.
    Grunebaum MF; Galfalvy HC; Huang YY; Cooper TB; Burke AK; Agnello M; Oquendo MA; Mann JJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):281-3. PubMed ID: 19154631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.
    Ide S; Kobayashi H; Ujike H; Ozaki N; Sekine Y; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Iwata N; Tanaka K; Shen H; Iwahashi K; Itokawa M; Minami M; Satoh M; Ikeda K; Sora I
    Pharmacogenomics J; 2006; 6(3):179-88. PubMed ID: 16402083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence.
    Otani K; Ujike H; Sakai A; Okahisa Y; Kotaka T; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Neurosci Lett; 2008 Mar; 434(1):88-92. PubMed ID: 18280655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis.
    Matsuzawa D; Hashimoto K; Miyatake R; Shirayama Y; Shimizu E; Maeda K; Suzuki Y; Mashimo Y; Sekine Y; Inada T; Ozaki N; Iwata N; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Hata A; Sawa A; Iyo M
    Am J Psychiatry; 2007 Jul; 164(7):1105-14. PubMed ID: 17606663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.